Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706).
EJHaem
; 2022 Aug 30.
Article
en En
| MEDLINE
| ID: mdl-36248617
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
EJHaem
Año:
2022
Tipo del documento:
Article